These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

25 related articles for article (PubMed ID: 344118)

  • 1. Lymphocyte subpopulations in insulin-dependent diabetics with and without serum islet-cell autoantibodies.
    Bersani G; Zanco P; Padovan D; Betterle C
    Diabetologia; 1981; 20(1):47-50. PubMed ID: 7009284
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence of delayed beta-cell destruction in type 1 (insulin-dependent) diabetic patients with persisting complement-fixing cytoplasmic islet cell antibodies.
    Mustonen A; Knip M; Huttunen NP; Puukka R; Käär ML; Akerblom HK
    Diabetologia; 1984 Oct; 27(4):421-6. PubMed ID: 6391985
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Duration of residual B-cell function in maturity-onset diabetes.
    Cignarelli M; Cospite MR; Stefanelli G; Guastamacchia E; Nardelli G; Giorgino R
    Acta Diabetol Lat; 1984; 21(2):161-6. PubMed ID: 6382892
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of residual B cell function and its metabolic consequences in Type 1 (insulin-dependent) diabetes.
    Madsbad S
    Diabetologia; 1983 Mar; 24(3):141-7. PubMed ID: 6341142
    [No Abstract]   [Full Text] [Related]  

  • 5. Epidemiology of islet cell antibodies.
    Lipton R; LaPorte RE
    Epidemiol Rev; 1989; 11():182-203. PubMed ID: 2680555
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pancreatic islet-cell antibodies in diabetes mellitus correlated with the duration and type of diabetes, coexistent autoimmune disease, and HLA type.
    Irvine WJ; McCallum CJ; Gray RS; Campbell CJ; Duncan LJ; Farquhar JW; Vaughan H; Morris PJ
    Diabetes; 1977 Feb; 26(2):138-47. PubMed ID: 320073
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Islet-cell antibodies and beta-cell function in insulin-dependent diabetics.
    Madsbad S; Bottazzo GF; Cudworth AG; Dean B; Faber OK; Binder C
    Diabetologia; 1980 Jan; 18(1):45-7. PubMed ID: 6988264
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Islet-cell antibodies and HLA type in Japanese insulin-dependent diabetics.
    Sakurami T; Nagaoka K; Nabeya N; Imura H; Kuno S
    Endocrinol Jpn; 1980 Apr; 27(2):149-52. PubMed ID: 6997023
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Islet cell antibodies and histocompatibility antigens (HLA) in insulin-dependent diabetics and their first-degree relatives.
    Barbosa J; Chavers B; Dunsworth T; Michael A
    Diabetes; 1982 Jul; 31(7):585-8. PubMed ID: 6761195
    [No Abstract]   [Full Text] [Related]  

  • 10. Immune complexes in type I diabetics with persistent islet cell antibodies.
    Irvine WJ; Di Mario U; Guy K; Borsey DQ
    J Clin Lab Immunol; 1980 Sep; 4(2):87-9. PubMed ID: 7003148
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Islet function in diabetics with persistent islet cell antibodies.
    Theophanides CG; Pyke DA; Watkins PJ
    Diabetes; 1978; 27 Suppl 1():265-6. PubMed ID: 344118
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunity and autoimmunity in diabetes mellitus.
    Christy M; Deckert T; Nerup J
    Clin Endocrinol Metab; 1977 Jul; 6(2):305-32. PubMed ID: 330037
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.